Phreesia, Inc.PHRNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank17
3Y CAGR+2.8%
5Y CAGR-30.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+2.8%/yr
vs -57.5%/yr prior
5Y CAGR
-30.1%/yr
Recent acceleration
Acceleration
+60.3pp
Accelerating
Percentile
P17
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.61% |
| Q3 2025 | -8.03% |
| Q2 2025 | 7.44% |
| Q1 2025 | 1.06% |
| Q4 2024 | -0.77% |
| Q3 2024 | 2.29% |
| Q2 2024 | -3.29% |
| Q1 2024 | 4.62% |
| Q4 2023 | 3.91% |
| Q3 2023 | 3.79% |
| Q2 2023 | 4.22% |
| Q1 2023 | 12.04% |
| Q4 2022 | 0.56% |
| Q3 2022 | 9.24% |
| Q2 2022 | 17.95% |
| Q1 2022 | 14.55% |
| Q4 2021 | 33.47% |
| Q3 2021 | 42.08% |
| Q2 2021 | 26.73% |
| Q1 2021 | 10.87% |
| Q4 2020 | 3.65% |
| Q3 2020 | 10.49% |
| Q2 2020 | 2.98% |
| Q1 2020 | 1.80% |
| Q4 2019 | 1.79% |
| Q3 2019 | 9.10% |
| Q2 2019 | 2.22% |
| Q1 2019 | 9.06% |
| Q4 2018 | 21.30% |
| Q3 2018 | 2.26% |
| Q2 2018 | 0.00% |